{"public_id":"co_d95fad42e0244f338fe505e33bc47750","status":"active","merged_into_public_id":null,"resolved_public_id":"co_d95fad42e0244f338fe505e33bc47750","name":"screening mammography","description":"Mammographic imaging used to screen asymptomatic women for breast cancer.","aliases":["mammography screening"],"types":["screening modality"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":75785740,"title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.","citation_count":1798,"url":"https://sah.borca.ai/papers/75785740"}],"claims":[{"public_id":"cl_055c1e2b153af30a0aacc7e8ec854377","text":"Routine screening mammography is recommended against for women aged 40 to 49 years.","corpus_id":75785740,"url":"https://sah.borca.ai/claims/cl_055c1e2b153af30a0aacc7e8ec854377"},{"public_id":"cl_7cbc57ae474c38e9dd4faba33323bde3","text":"Regular biennial screening mammography before age 50 should be an individual decision that accounts for patient context and values regarding benefits and harms.","corpus_id":75785740,"url":"https://sah.borca.ai/claims/cl_7cbc57ae474c38e9dd4faba33323bde3"},{"public_id":"cl_a73cc768cfbf07c676393de453be1966","text":"Current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older, of clinical breast examination beyond screening mammography in women 40 years or older, and of digital mammography or magnetic resonance imaging instead of film mammography.","corpus_id":75785740,"url":"https://sah.borca.ai/claims/cl_a73cc768cfbf07c676393de453be1966"},{"public_id":"cl_d50bd8d174d4cddcff270ad7a585678c","text":"Biennial screening mammography is recommended for women between ages 50 and 74 years.","corpus_id":75785740,"url":"https://sah.borca.ai/claims/cl_d50bd8d174d4cddcff270ad7a585678c"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_d95fad42e0244f338fe505e33bc47750","url":"https://sah.borca.ai/concepts/co_d95fad42e0244f338fe505e33bc47750"}